The high frequent germline mutation in GAB2 was also present in acute myeloid leukemia in the International Cancer Genome Consortium study and in acute lymphoblastic leukemia with Ras-independent leukemogenic effects [49]. The gene discussed is GAB2; the disease is acute myeloid leukemia.